Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfasalazine for Prevention of Radiation-Induced Diarrhea
NCT01198145Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Apr 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in radiation enteritis comparing Sulfasalazine with Placebo (2 arms). Primary endpoint: Maximum Severity of Diarrhea Toxicity as Measured by the CTCAE v4.0. Started Apr 2011; status: completed.
02
Drugs
5-aminosalicylic acid + sulphasalazine
03
Conditions
radiation enteritis
Beyond the preview
Go deeper on NCT01198145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198145.